Hey Psychedelic Investors, today we are actually going to have two episodes, one to present the news updates, and then a second one, which will take place in the Speculation Zone to discuss why these may be super important So make sure you stick around for both. Timecodes: 0:00 - Intro 3:30 - New Phase 1 Clinical Trial 9:45 - Changes in Leadership 13:19 - New MindMed Partnership 20:30 - Conclusion So what is the latest MindMed news and what does it mean for the future of MMED/MMEDF? First up, we have news from the end of January that MindMed has started their phase one clinical trial combining MDMA with LSD. Why combine these two substances? What diseases could it help alleviate? And what is the timeline for this project? Next we will cover MindMed's change in leadership structure. A CEO has stepped down, does this mean we are seeing a game of thrones in the boardroom? Well… no. It's actually much more practical than that. Here we will cover: Why did they do this, and how will it affect MMED/MMEDF going forward, specifically with MindMed 's Nasdaq Uplisting application. Finally, and most importantly, we will talk about how MindMed is further expanding their development pipeline and IP portfolio through a partnership with a Swiss company called MindShift Compounds. This is very exciting as it ads to MindMed's ever expanding clinical trial pipeline. Pretty soon it's going to be hard keeping track of all of MindMed's projects. Hey there guys so before we begin the episode I just want to let you know that I was just interviewed on the channel The Medicine of being Human. We talked about all sorts of interesting topics and I had a great time. I am not sure if by the time this video is released, if the interview will already be out, but ill put a link in the description to the Channel, and also to Sena’s Instagram page. https://www.youtube.com/channel/UChW422KBFaEfB9DJG_cKySQ https://www.instagram.com/sena__maria/ I hope you guys found some value in this and I'll keep you posted for more changes! Remember to Like, Subscribe, and SMASH that notifications bell to keep up to date on all the latest Psychedelic Stocks news! Follow us on social media! 🙌 Instagram: @psychedelicinvestor Facebook: @thepsychedelicinvestor Music: www.bensound.com Video from Pexels DISCLAIMER: I am not a financial adviser nor a CPA. These videos are for educational and entertainment purposes only. Investing of any kind involves risk. While it is possible to minimize risk, your investments are solely your responsibility. It is imperative that you conduct your own research. I am merely sharing my opinion with no guarantee of gains or losses on investments. #MindMed #MMEDF #MindmedStock

Hello Psychedelic Investors! Today, we will focus on MindMed's 2021 Investors Deck and Project Lucy & Project Layla's clinical trials updates. MindMed, ticker symbol MMED on the Canadian NEO Stock exchange, and MMEDF on the American OTC Market has updated their 2021 Investors Deck (TWICE) in this year. As a fellow MindMed geek, I did my due diligence to compare the information on both decks and there's a few clinical trial changes and a few other updates I found important to discuss. In this episode, we will discuss: Timecodes 0:00 - Intro 3:02 - MindMed's Project Lucy Updates 6:27 - MMED's18-MC And Microdosing Updates 9:00 - LSD to treat Suicide Headaches 11:04 - Phase 1 Updates 14:06 - Stats Updates 15:32 - MindMed Stock Speculation Zone Important to mention that after we shot this video, MindMed did answer our inquiry about the removed readout with "Hello - Sorry for the delay. We plan on filing the IND for Project Lucy in Q3 of 2021." I'm not sure if that means that there will be a readout in Q3 as well... I hope you guys found some value in this and I'll keep you posted for more changes! Remember to Like, Subscribe, and SMASH that notifications bell to keep up to date on all the latest Psychedelic Stocks news! Follow us on social media! 🙌 Instagram: @psychedelicinvestor Facebook: @thepsychedelicinvestor Music: www.bensound.com Video by Pressmaster from Pexels DISCLAIMER: I am not a financial adviser nor a CPA. These videos are for educational and entertainment purposes only. Investing of any kind involves risk. While it is possible to minimize risk, your investments are solely your responsibility. It is imperative that you conduct your own research. I am merely sharing my opinion with no guarantee of gains or losses on investments. #MindMed #MMEDF #MindmedStock

Clinical trials will look at the benefits of 5-MEO DMT as a treatment for relief from a number of mental health issues including depression.